Physician profile
Danielle Bachman
NPI 1437691011
$395.55
in general payments reported to CMS, 2019-2025
13 companies · $59.38 in 2025
The $59.38 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $141 · 2023: $90.06 · 2024: $105 · 2025: $59.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $254.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $69.14 | 2022 | |
| Eisai INC. | $66.88 | 2023-2024 | |
| Csl Behring | $53.20 | 2022-2025 | Hizentra |
| Abbvie INC. | $34.29 | 2023 | |
| Lundbeck LLC | $28.85 | 2022 | |
| Ucb, INC. | $25.60 | 2024 | Briviact |
| Argenx US, INC. | $22.61 | 2024 | |
| Tonix Medicines, INC. | $18.36 | 2025 | Zembrace Symtouch |
| Solventum Corporation | $17.52 | 2025 | V.A.C. Veraflo, Prevena |
| Banner Life Sciences, LLC | $15.56 | 2024 | |
| Kyowa Kirin, INC. | $15.21 | 2023 | Nourianz |
| Teva Pharmaceuticals USA, INC. | $14.70 | 2024 | Austedo Xr |
| Neurocrine Biosciences, INC. | $13.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Bachman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.